Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Emerging critical role of molecular testing in diagnostic genitourinary pathology.

Netto GJ, Cheng L.

Arch Pathol Lab Med. 2012 Apr;136(4):372-90. doi: 10.5858/arpa.2011-0471-RA. Review.

2.

Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?

Netto GJ.

Nat Rev Urol. 2011 Dec 13;9(1):41-51. doi: 10.1038/nrurol.2011.193. Review.

PMID:
22158597
3.

Molecular genetics and genomics progress in urothelial bladder cancer.

Netto GJ.

Semin Diagn Pathol. 2013 Nov;30(4):313-20. doi: 10.1053/j.semdp.2013.11.005. Review.

PMID:
24342287
4.

Molecular diagnostics in urologic malignancies: a work in progress.

Netto GJ.

Arch Pathol Lab Med. 2011 May;135(5):610-21. doi: 10.1043/2010-0727-RAIR.1. Review.

PMID:
21526959
5.

Clinical applications of recent molecular advances in urologic malignancies: no longer chasing a "mirage"?

Netto GJ.

Adv Anat Pathol. 2013 May;20(3):175-203. doi: 10.1097/PAP.0b013e3182863f80. Review.

PMID:
23574774
6.

[Molecular diagnostics in urologic oncology. Detection of nucleic acids in urine samples].

Müller M, Goessl C, Krause H, Miller K.

Urologe A. 2003 May;42(5):660-8. Review. German.

PMID:
12750801
7.

The role of genetic markers in the management of prostate cancer.

Choudhury AD, Eeles R, Freedland SJ, Isaacs WB, Pomerantz MM, Schalken JA, Tammela TL, Visakorpi T.

Eur Urol. 2012 Oct;62(4):577-87. doi: 10.1016/j.eururo.2012.05.054. Review.

PMID:
22695242
8.

Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.

Higgins JP, Kaygusuz G, Wang L, Montgomery K, Mason V, Zhu SX, Marinelli RJ, Presti JC Jr, van de Rijn M, Brooks JD.

Am J Surg Pathol. 2007 May;31(5):673-80.

PMID:
17460449
9.

Theranostic and prognostic biomarkers: genomic applications in urological malignancies.

Netto GJ, Epstein JI.

Pathology. 2010 Jun;42(4):384-94. doi: 10.3109/00313021003779145. Review.

PMID:
20438413
10.

Prognostic and predictive miRNA biomarkers in bladder, kidney and prostate cancer: Where do we stand in biomarker development?

Schubert M, Junker K, Heinzelmann J.

J Cancer Res Clin Oncol. 2016 Aug;142(8):1673-95. doi: 10.1007/s00432-015-2089-9. Review.

PMID:
26660324
11.

Intratumour heterogeneity in urologic cancers: from molecular evidence to clinical implications.

Gerlinger M, Catto JW, Orntoft TF, Real FX, Zwarthoff EC, Swanton C.

Eur Urol. 2015 Apr;67(4):729-37. doi: 10.1016/j.eururo.2014.04.014. Review.

PMID:
24836153
12.

The role of methylation in urological tumours.

van der Heijden AG.

Arch Esp Urol. 2013 Jun;66(5):432-9. Review.

PMID:
23793761
13.

Selected common diagnostic problems in urologic pathology: perspectives from a large consult service in genitourinary pathology.

Brimo F, Epstein JI.

Arch Pathol Lab Med. 2012 Apr;136(4):360-71. doi: 10.5858/arpa.2011-0187-RA. Review.

PMID:
22458899
14.

[Prognostic and predictive molecular markers for urologic cancers].

Hartmann A, Schlomm T, Bertz S, Heinzelmann J, Hölters S, Simon R, Stoehr R, Junker K.

Urologe A. 2014 Apr;53(4):491-500. doi: 10.1007/s00120-014-3442-3. Review. German.

PMID:
24700189
15.

Emerging Bladder Cancer Biomarkers and Targets of Therapy.

Netto GJ, Tafe LJ.

Urol Clin North Am. 2016 Feb;43(1):63-76. doi: 10.1016/j.ucl.2015.08.006. Review.

PMID:
26614029
16.

MicroRNA in prostate, bladder, and kidney cancer: a systematic review.

Catto JW, Alcaraz A, Bjartell AS, De Vere White R, Evans CP, Fussel S, Hamdy FC, Kallioniemi O, Mengual L, Schlomm T, Visakorpi T.

Eur Urol. 2011 May;59(5):671-81. doi: 10.1016/j.eururo.2011.01.044. Review.

PMID:
21296484
17.

[Tumor markers in the histopathology of urologic tumors].

Hofstädter F.

Urologe A. 1987 Jan;26(1):2-6. German.

PMID:
3576859
18.

Molecular biomarkers for predicting outcomes in urothelial carcinoma of the bladder.

Sapre N, Herle P, Anderson PD, Corcoran NM, Hovens CM.

Pathology. 2014 Jun;46(4):274-82. doi: 10.1097/PAT.0000000000000110. Review.

PMID:
24798156
19.

Molecular diagnostic trends in urological cancer: biomarkers for non-invasive diagnosis.

Urquidi V, Rosser CJ, Goodison S.

Curr Med Chem. 2012;19(22):3653-63. Review.

20.

Urine microRNAs as potential noninvasive biomarkers in urologic cancers.

Mlcochova H, Hezova R, Stanik M, Slaby O.

Urol Oncol. 2014 Jan;32(1):41.e1-9. doi: 10.1016/j.urolonc.2013.04.011. Review.

PMID:
24035473

Supplemental Content

Support Center